Allergan Pharmaceuticals Ireland is to invest $350 million in its Westport operation to expand its development and manufacturing capabilities. The expansion will result in the creation of around 200 new jobs at the site over the next four years and an estimated 250 indirect jobs locally, during the construction period.
This investment will enable Allergan to expand the manufacturing capacity for Botox and to develop a manufacturing base for the next generation of products.
Welcoming the investment, IDA Ireland CEO, Barry O’Leary said: “I am delighted to welcome Allergan’s decision to locate this investment at its Westport operation. Allergan already contributes significantly to the national and local economies, investing an average of $25 million capital expenditure per annum in Ireland, in recent years.
